CXCL2 and chronic obstructive pulmonary disease: We hypothesized that GG, AR, and their mixture might be able to limit CFA-induced inflammatory response in a mouse model of COPD and confirm the involvement of the CXCL-2, IL-17/STAT3 pathway in the observed therapeutic effects.